Morgan Stanley estimated in 2024 that employer GLP-1 coverage generates USD 8,200 in annual healthcare cost savings per successfully treated employee with obesity generating positive ROI within 3 to 5 years
Many patients have safely reduced steroid or extra DMARD and biologic use
For autoimmune conditions, where those goals may not apply, lower doses may theoretically make sense
If retatrutide prevents type 2 diabetes ($9,600 per year average treatment cost), cardiovascular disease ($20,000+ per year), or joint replacement surgery ($50,000 one-time cost), it pays for itself within 1-2 years even at full price
doi:10.2337/dc13-2759
When stomach acid comes into contact with your teeth repeatedlywhether through vomiting or acid refluxit erodes tooth enamel, making teeth more vulnerable to decay and sensitivity